Intellia’s CRISPR/Cas9 proprietary process produces multiple, highly efficient sequential edits in T cells that have superior function and minimal translocations, compared to results from standard T ...

When a financial institution creates a new business partnership with individuals or organizations without fully knowing their past and present business dealings, it can expose them to hefty lawsuits, ...